Literature DB >> 3778806

DNA content and prognosis of non-Hodgkin's lymphoma.

D R Morgan, J M Williamson, P Quirke, A D Clayden, M E Smith, C J O'Brien, D L Allison, J A Child, C C Bird.   

Abstract

Ninety cases of non-Hodgkin's lymphoma diagnosed prior to the use of modern therapeutic regimens (1963-67) and 88 cases treated with such chemotherapy (1980-85) were studied using conventional morphology and flow cytometry. DNA aneuploidy as determined by flow cytometry was more common among high grade (38%) than low grade (19%) tumours (P less than 0.01). Measurements of proliferative index (S + G2 phase cells) revealed significantly increased values for high grade as compared with low grade lymphomas (P less than 0.001). In the first group of cases (1963-67) the relationship between histological grade and survival just failed to reach statistical significance over the long term (20 yr) (P = 0.1) but proved significant over 3 yr (P = 0.012). Differences in ploidy and proliferative index status were not associated with survival. In the second patient group (1980-85) attainment of complete remission following chemotherapy was associated with the presence of DNA aneuploidy in high grade tumours (P less than 0.05). The limited follow up of this group precluded assessment of survival in relation to ploidy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3778806      PMCID: PMC2001503          DOI: 10.1038/bjc.1986.221

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  16 in total

1.  The biology of tumor growth in the non-Hodgkin's lymphomas. A dual parameter flow cytometry study of 220 cases.

Authors:  S E Shackney; A M Levine; R I Fisher; P Nichols; E Jaffe; W H Schuette; R Simon; C A Smith; S J Occhipinti; J W Parker
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

2.  Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma.

Authors:  A T Look; F A Hayes; R Nitschke; N B McWilliams; A A Green
Journal:  N Engl J Med       Date:  1984-07-26       Impact factor: 91.245

3.  Prognostic significance of DNA-analysis by flow cytometry in non-Hodgkin's lymphoma.

Authors:  G Roos; U Dige; P Lenner; J Lindh; H Johansson
Journal:  Hematol Oncol       Date:  1985 Oct-Dec       Impact factor: 5.271

4.  The clonal evolution of tumor cell populations.

Authors:  P C Nowell
Journal:  Science       Date:  1976-10-01       Impact factor: 47.728

Review 5.  Clinical and biological significance of aneuploidy in human tumours.

Authors:  M L Friedlander; D W Hedley; I W Taylor
Journal:  J Clin Pathol       Date:  1984-09       Impact factor: 3.411

6.  Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry.

Authors:  D W Hedley; M L Friedlander; I W Taylor; C A Rugg; E A Musgrove
Journal:  J Histochem Cytochem       Date:  1983-11       Impact factor: 2.479

7.  Influence of cellular DNA content on survival in advanced ovarian cancer.

Authors:  M L Friedlander; D W Hedley; I W Taylor; P Russell; A S Coates; M H Tattersall
Journal:  Cancer Res       Date:  1984-01       Impact factor: 12.701

8.  Flow cytometry in the diagnosis and classification of malignant lymphoma and leukemia.

Authors:  L W Diamond; B N Nathwani; H Rappaport
Journal:  Cancer       Date:  1982-09-15       Impact factor: 6.860

9.  Genetic instability coupled to clonal selection as a mechanism for tumor progression in the Dunning R-3327 rat prostatic adenocarcinoma system.

Authors:  J T Isaacs; N Wake; D S Coffey; A A Sandberg
Journal:  Cancer Res       Date:  1982-06       Impact factor: 12.701

10.  DNA content analysis by flow cytometry and cytogenetic analysis in mycosis fungoides and Sézary syndrome.

Authors:  P A Bunn; J Whang-Peng; D N Carney; M L Schlam; T Knutsen; A F Gazdar
Journal:  J Clin Invest       Date:  1980-06       Impact factor: 14.808

View more
  7 in total

1.  Prognostic significance of DNA flow cytometry in non-Hodgkin's lymphoma.

Authors:  H M Wu
Journal:  J Tongji Med Univ       Date:  1992

Review 2.  Review: assessment of cell proliferation in histological material.

Authors:  P A Hall; D A Levison
Journal:  J Clin Pathol       Date:  1990-03       Impact factor: 3.411

3.  Prognostic indicators in centroblastic-centrocytic lymphoma.

Authors:  N R Griffin; M R Howard; P Quirke; C J O'Brien; J A Child; C C Bird
Journal:  J Clin Pathol       Date:  1988-08       Impact factor: 3.411

4.  Influence of preoperative radiotherapy on DNA ploidy in squamous cell carcinomas of the oesophagus.

Authors:  R Porschen; G Bevers; U Remy; S Schauseil; F Borchard
Journal:  Gut       Date:  1993-08       Impact factor: 23.059

5.  DNA content in high and intermediate grade non-Hodgkin's lymphoma-prognostic significance and clinicopathological correlations.

Authors:  R A Cowan; M Harris; M Jones; D Crowther
Journal:  Br J Cancer       Date:  1989-12       Impact factor: 7.640

Review 6.  Prognostic factors in the non-Hodgkin's lymphomas--a time for consensus?

Authors:  J A Child
Journal:  Br J Cancer       Date:  1991-06       Impact factor: 7.640

7.  Prognostic factors in high and intermediate grade non-Hodgkin's lymphoma.

Authors:  R A Cowan; M Jones; M Harris; W P Steward; J A Radford; J Wagstaff; D P Deakin; D Crowther
Journal:  Br J Cancer       Date:  1989-02       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.